• OPEN AN ACCOUNT
Indian Indices
Sensex
83,739.13 2,072.67
( 2.54%)
Global Indices
Nasdaq
49,433.27 519.79
(1.06%)
Dow Jones
6,997.90 37.87
(0.54%)
Hang Seng
54,706.11 2,050.93
(3.90%)
Nikkei 225
10,302.23 -39.33
(-0.38%)
Forex
USD-INR
91.61 -0.04
(-0.05%)
EUR-INR
108.55 -0.05
(-0.05%)
GBP-INR
125.35 -0.06
(-0.05%)
JPY-INR
0.59 0.00
(-0.07%)

EQUITY - MARKET SCREENER

Zydus Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532321
INE010B01027
215.0764496
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ZYDUSLIFE
18.83
90857.9
EPS(TTM)
Face Value()
Div & Yield %
47.96
1
1.22
 

ifci ltd
M&M production jumps 25% YoY in December’25
Jan 12,2026
The auto major's total sales stood at 85,501 units in December 2025, registering a growth of 25.41% on a YoY basis while exports fell 9.33% YoY to 3,063 units in December 2025.

Mahindra & Mahindra (M&M) Group enjoys a leadership position in farm equipment, utility vehicles, information technology, and financial services in India. It is the world's largest tractor company by volume. It has a strong presence in renewable energy, agriculture, logistics, hospitality and real estate.

On a standalone basis, the company’s net profit surged 17.7% to Rs 4,520.52 crore on a 21.3% rise in revenue from operations to Rs 33,421.60 crore in Q2 FY26 over Q2 FY25, reflecting broad-based growth across Auto and Farm segments.

The scrip declined 1.84% to Rs 3,607.50 on the BSE.